Welcome : Guest

Dawnrays Pharmaceutical (Holdings) Ltd. (Hong Kong ) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Dawnrays Pharmaceutical (Holdings) Ltd., which is principally involved in providing Non-Patented Pharmaceutical Medicines. Illustrated with 102 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-33325
Price: $3500
Company Type: Public
Pages: 104
Date: November 2016
Market Data Tables: 102

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Dawnrays Pharmaceutical Holdings Ltd.’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Intermediates and Bulk Medicines, and Finished Drugs......3
Table 2: Dawnrays Pharmaceutical Holdings Ltd.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Mainland China, and Other Countries......4
Hepatitis B......5
Table 3: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......5
Table 4: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......6
Table 5: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......7
Antibiotics......8
Table 6: Antibiotics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......8
Table 7: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......9
Table 8: Antibiotics Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......10
Table 9: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......11
Allergy Drugs......12
Table 10: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others......12
Table 11: Allergy Care Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......13
Table 12: US Market (Private Label and Others) by Product (2015) - Percentage Share Breakdown by Values Sales for Allergy Care, Baby Food, Bakery, Bleach, Dairy, Deodorants, Hair Care, Ice Cream, Laundry Care, Oral Care, OTC, Pet Food, Pet Products, Retail Tissue, Sauces/Dressing, Skin Care, Sun Care, Toilet Care and VDS......14
Dermatological Drugs......15
Table 13: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......15
Table 14: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......16
Table 15: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......17
Table 16: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......18
Table 17: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......19
Urology......20
Table 18: Urology and Gynaecology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Dialysis Equipment, Gynaecology Devices, Urinary Catheters, and Urology Devices......20
Table 19: Urology Care Market by Region Worldwide (2015) - Percentage Share Breakdown for Europe, North America, and Rest of World (RoW)......21
Table 20: Urology Market by Category in North America and Europe (2015) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......22
Table 21: Urology Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties......23
Table 22: Urology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......24
Urinary Incontinence Drugs......25
Table 23: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......25
Table 24: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......26
Infectious Disease Drugs......27
Table 25: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......27
Table 26: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......28
Rheumatoid Arthritis......29
Table 27: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......29
Anti-Osteoarthritis......30
Table 28: Anti-Osteoarthritis Market in Korea (2015-2020) in KRW Million......30
Cardiovascular......31
Table 29: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......31
Table 30: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......32
Table 31: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......33
Diabetes......34
Table 32: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......34
Table 33: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......35
Table 34: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......36
Table 35: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......37
Table 36: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......38
Table 37: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......39
Table 38: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......40
Table 39: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......41
Table 40: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......42
Table 41: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......43
Diabetes Drugs......44
Table 42: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......44
Table 43: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......45
Table 44: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......46
Table 45: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......47
Table 46: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......48
Table 47: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......49
Table 48: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......50
Table 49: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......51
Table 50: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......52
Table 51: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......53
Table 52: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......54
Non-Insulin Anti-Diabetic Drugs......55
Table 53: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......55
Diabetic Macular Edema (DME)......56
Table 54: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......56
Table 55: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......57
DPP-4 Inhibitors......58
Table 56: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......58
Table 57: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......59
Table 58: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......60
Table 59: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......61
Table 60: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......62
Table 61: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......63
DPP-4 type Diabetes Drugs......64
Table 62: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......64
Traditional Chinese Medicine (TCM)......65
Table 63: Traditional Chinese Medicine (TCM) Market for Cardiovascular by Drug in China (2015) - Percentage Share Breakdown by Value for Fufang Danshen Dripping Pill, Naoxintong Capsule and Others......65
Table 64: Traditional Chinese Medicine (TCM) Market for Cerebral Nervous System by Drug in China (2015) - Percentage Share Breakdown by Value for Tianmasuo Injection, Wuling Capsule, Yangxue Qongnal Granule and Others......66
Table 65: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......67
Amlodipine Besylate Tablets......68
Table 66: Market Shares of Leading Amlodipine Besylate Tablet Manufacturers for Antihypertensive Therapy Worldwide (2015) - Percentage Share Breakdown by Hospital Sales for Pfizer, Inc., Saike Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, and Others......68
Telmisartan Tablet......69
Table 67: Market Shares of Leading Telmisartan Tablet Manufacturers for Antihypertensive Therapy Worldwide (2015) - Percentage Share Breakdown by Hospital Sales for C. H. Boehringer Sohn AG & Co. KG, Hainan Sailike Pharmaceutical Industry Ltd., Yichang Changjiang Pharmaceutical Co., Ltd., and Others......69
Bismuth Potassium Citrate......70
Table 68: Market Shares of Leading Bismuth Potassium Citrate Manufacturers in China (2015) - Percentage Share Breakdown by Value for Dawnrays Pharmaceutical (Holdings) Limited., Jiangsu Zhongdan Pharmaceutical Co., Ltd., Livzon Pharmaceutical Group Inc. and Others......70
HBV/HCV Therapeutics......71
Table 69: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......71
Table 70: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......72
Antibiotics......73
Table 71: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......73
Table 72: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......74
Allergy Care Products......75
Table 73: Market Shares of Leading Allergy Immunotherapy Treatment Providers Worldwide (2015) - Percentage Breakdown by Value for ALK-Abelló, Greer Laboratories, Inc., and Others......75
Table 74: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......76
Table 75: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......77
Table 76: Allergy Drug Market in the UK (2015) - Percentage Share Breakdown by Value for Allegra, Allelock, Clarinex, Claritin, Zyrtec, and Others......78
Dermatological Products......79
Table 77: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......79
Table 78: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......80
Table 79: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......81
Table 80: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......82
Digestive Remedies......83
Table 81: Market Shares of Leading Digestive Remedy Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Procter & Gamble Co., Reckitt Benckiser Plc, and Others......83
Table 82: Market Shares of Leading Digestive Tablet Brands in India (2014) - Percentage Breakdown by Value Sales for Hajmola, Satmola and Others......84
Urinary Incontinence Therapeutics......85
Table 83: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......85
Anti-Osteoarthritis Medicine......86
Table 84: Market Shares of Leading Anti-Osteoarthritis Medicine Manufacturers in Korea (2015) - Percentage Breakdown by Value for Humedix Co., Ltd., and Others......86
Cardiology Therapeutics......87
Table 85: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......87
Infectious Disease Drugs......88
Table 86: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......88
Gliclazide Tablets......89
Table 87: Market Shares of Leading Gliclazide Tablet Brands in Brazil (2015) - Percentage Share Breakdown by Value for Servier - Diamicron MR, and Torrent- Azukon MR......89
Diabetes Drugs......90
Table 88: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......90
Table 89: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......91
Table 90: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......92
DPP-4 Inhibitors......93
Table 91: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......93
Table 92: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......94
Table 93: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......95
Sitagliptin/Metformin......96
Table 94: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......96
Table 95: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......97
Table 96: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......98
Table 97: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......99
Metformin......100
Table 98: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......100
Traditional Chinese Medicine (TCM)......101
Table 99: Market Shares of Leading Traditional Chinese Medicine (TCM) Manufacturers for Treating Kidney Disease in China (2015) - Percentage Share Breakdown by Value for Changchun High-tech Industry (Group) Co., Ltd., Consun Pharmaceutical Group Ltd., Jilin Province Huinan Changlong Bio-Pharmacy Co., Ltd., SZYY Pharmaceutical Co., Ltd., Tianjin Tongrentang Group, and Others......101
Table 100: Market Shares of Leading Traditional Chinese Medicine Injections for Treatment of Anti-Cancer in China (2015) - Percentage Share Breakdown by Value for Aidi Injection, Fufang Kushen Injection, Kangai Injection, Kanglaite Injection, Shenqi Fuzheng Injection and Others......102
Table 101: Dawnrays Pharmaceutical Holdings Ltd.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Mainland China and Other Countries......103
Table 102: Dawnrays Pharmaceutical Holdings Ltd.’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Intermediates and Bulk Medicines and Finished Drugs......104